GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Ltd (NSE:PFIZER) » Definitions » Total Payout Ratio

Pfizer (NSE:PFIZER) Total Payout Ratio : 0.00 (As of Jun. 25, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Pfizer Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Pfizer's current Total Payout Ratio is 0.00.


Pfizer Total Payout Ratio Historical Data

The historical data trend for Pfizer's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Total Payout Ratio Chart

Pfizer Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 2.27 0.21 0.36 0.25

Pfizer Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pfizer's Total Payout Ratio

For the Drug Manufacturers - General subindustry, Pfizer's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Total Payout Ratio falls into.



Pfizer Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Pfizer's Total Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + -1834.3) / 7460.7
=0.25

Pfizer's Total Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / 1788.6
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pfizer Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Pfizer's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (NSE:PFIZER) Business Description

Traded in Other Exchanges
Address
The Capital, 1802/1901, 18th Floor, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Pfizer Ltd is a major drug manufacturing company that focuses on a global portfolio of medical products. The company works across developed and emerging markets to advance treatments through its two segments, Pfizer Innovative Health and Pfizer Essential Health. The vast majority of the company's revenue is derived from the manufacture and sale of biopharmaceutical products. most of the company's sales are generated by its Innovative Health segment. While the company operates across a wide span of international markets, most of the company's revenue is generated in India.

Pfizer (NSE:PFIZER) Headlines

No Headlines